Search results
Results from the WOW.Com Content Network
Some make use of SBRT (stereotactic body radiation therapy), a very precise radiation technique able to provide high doses with minimal side effects. Most trials of LCT in NSCLC focus on oligometastatic disease (under 3-5 lesions, depending on the definitions), but preliminary results of the BRIGHTSTAR trial [ 24 ] indicate this method may be ...
The oncologist, per the Stanford Medicine blog Scope, was diagnosed with non-small cell cancer — also known as never-smoker lung cancer — in early May, around a month before his 50th birthday.
The causes of lung cancer among people who have never smoked remain unclear, but experts suspect a combination of environmental, genetic, and lifestyle-related factors play a role.
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer.The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy ...
Adenocarcinoma of the lung is currently the most common type of lung cancer in "never smokers" (lifelong nonsmokers). [10] Adenocarcinomas account for about 40% of lung cancers. Historically, adenocarcinoma was more often seen peripherally in the lungs than SCLC and squamous-cell lung cancer, both of which tended to be more often centrally located.
In other lung cancer patients who never smoked, the U.S. Centers for Disease Control says "Researchers estimate that secondhand smoke contributes to about 7,300 and radon to about 2,900 of these ...
Chemotherapy for NSCLC usually includes combination of two drugs (chemotherapy doublet), with one of the agents is cisplatin or carboplatin. In 2002, Schiller at al. published in the New England Journal of Medicine, a study that compared four chemotherapy regimens for advanced NSCLC, cisplatin and paclitaxel, cisplatin and gemcitabine, cisplatin and docetaxel, and carboplatin and paclitaxel. [14]
Dr. Bryant Lin, a Stanford University School of Medicine physician and professor, has never smoked, but in early May 2024, he received a life-altering diagnosis: stage IV lung cancer.. Lung cancer ...